Sheng-e Song, Yuan Feng
Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi 530011, China
Lung cancer is one of the malignant tumors of the respiratory system, which has the fastest increase in morbidity and mortality in the past 100 years. What’s more, it threatens human health and life. The 2020 World Cancer Report states: Lung cancer is currently the leading cause of cancer deaths worldwide, accounting for about 18% of all cancer deaths . The National Cancer Center released the latest issue of national cancer statistics in 2019: Lung cancer is at the head of malignant tumor in China in terms of incidence (20.03%) and mortality (26.99%). Some Chinese medicines have good effects on inhibiting the growth and spread of cancer cells, and can significantly improve symptoms and patients’ quality of life in the treatment of lung cancer. Pattern of qi stagnation and blood stasis is one of the basic patterns of lung cancer patients, so the treatment of boosting qi and quickening the blood occupies an important position in the treatment of lung cancer.Professor Feng Yuan believes that the onset of lung cancer is the root vacuity and tip repletion, root based on qi vacuity and tip is the result of mutual influence of phlegm turbidity and depressed accumulation of static blood. Due to the long-term disease, the formation of the accumulation eventually leads to the formation of cancer. He pays special attention to in treatment, at the same time, combines with clinical practice and regards them as the basis for determining treatment. Consequently, he innovatively proposed to treat lung cancer of pattern qi vacuity with blood stasis by supplementing lung qi and quickening the blood and transform stasis.
Lung cancer, pattern qi vacuity with blood stasis, Bufei Huayu Decoction, FENG Yuan, Summary of experience
Sheng-e Song, Yuan Feng. Professor Feng Yuan's Experience in Treating Lung Cancer with Bufei Huayu Decoction. International Journal of Frontiers in Medicine (2021), Vol. 3, Issue 4: 51-56. https://doi.org/10.25236/IJFM.2021.030409.
 Wild c p, weiderpass e, stewart b w. world cancer report [M].2020.
 Feng Yuan , Chen Sining , Zhou Ying , Xia Ze , Lin Weinan , Zhu Lin , Song Shenge ,Wei Lulu , Li Jianzhe , Tang Fangmei , Jiang Ying.Clinical Study of Bufei Huayu Decoction Combined with Gefitinib in the Treatment of Advanced Non-Small Cell Lung Cancer[J].Acta Medica Mediterranea, 2020, 36:1815-1821.
 Ge Junbo, Xu Yongjian. Internal Medicine [M]. 8th edition. Beijing: People's Medical Publishing House, 2013.
 Guo Mi. Research progress on Qi deficiency and blood stasis syndrome in patients with advanced non-small cell lung cancer [J]. Contemporary Medicine, 2018, (02): 182-184.
 Sun Ying. Study on the characteristics of advanced non-small cell lung cancer syndrome types and blood stasis syndrome related factors [D]. Tianjin: Tianjin University of Traditional Chinese Medicine, 2020: 47-51.
 Fan Limeng, Zhang Fengxia, Sun Xiqing. Research progress of Qi deficiency and blood stasis syndrome in stroke [J]. World Traditional Chinese Medicine, 2014, 9(2): 257-260.
 Feng Yuan, Jiang Ying, Zhou Ying, Liu Rui, Xie Youke, Li Jianzhe, Zhu Lin, Lin Weinan, Song Shenge, Wei Lulu. Effect of Bufei Huayu Decoction on Lewis Lung Cancer Mice with Qi Deficiency and Blood Stasis Syndrome [J]. Chinese Patent Medicine, 2019, 41(11): 2625-2631.
 Li Ying, Wang Leisha, Liu Jianxun, Song Wenting, Xu Li, Li Honghai, Li Junmei, Yang Bin, Dong Xiaoxia, Wang Guangrui, Yao Mingjiang, Lin Chengren. Rat model characterization and pathophysiological changes of cerebral infarction with Qi deficiency and blood stasis syndrome [J].Chinese Traditional Medicine Magazine, 2018, 43(04):786-793.
 Feng Yuan, Jiang Ying, Zhou Ying, Liu Rui, Xie Youke, Li Jianzhe, Zhu Lin, Lin Weinan, Song Shenge, Wei Lulu.Bufei Huayu Decoction combined with Gefitinib in the treatment of EGFR-mutant advanced non-small cell lung cancer[J].Chinese Journal of Gerontology , 2019, 39(23): 5682-5686.
 Liu Ruoxuan, Li Arong, Guo Jiewen, Zeng Qingping, Li Wanjun, Cai Yinlian. Protective effect of Hedyotis diffusa on intrahepatic cholestasis model rats [J].Chinese Medicinal Materials, 2018, 41(6):1475-1478.
 Dong Yongcai, Shang Yazhen.Progress in pharmacology of Scutellaria barbata [J].Journal of Chengde Medical College, 2009, 26(1): 98-100.